IKZF1 DELETIONS DO NOT HAVE A STRONG IMPACT ON EVENT FREE SURVIVAL IN PATIENTS WITH B-PRECURSOR ALL TREATED ON THE UKALL14 TRIAL (ISRCTN 66541317)
EHA Library, Rachel Mitchell, 265950
THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVO
EHA Library, Klaudyna Fidyt, 265951
FREQUENCY AND PROGNOSTIC IMPACT OF ZEB2 H1038/Q1072 MUTATIONS IN CHILDHOOD B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Marketa Zaliova, 265952
TARGETING LYSOSOMES AS A POTENTIAL THERAPEUTIC APPROACH FOR T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Library, Antònia BANÚS MULET, 265953
CD9 IS AN ADVERSE PROGNOSTIC MARKER AND PROMISING THERAPEUTIC TARGET IN HIGH-RISK PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Chi ZHANG, 265954
THE XPO1 INHIBITOR KPT-8602 WORKS SYNERGISTIC WITH DEXAMETHASONE TO INHIBIT ACUTE LYMPHOBLASTIC LEUKEMIA CELLS
EHA Library, Delphine Verbeke, 265955
RASD1 INHIBITS THE PROLIFERATION OF LEUKEMIA CELLS AND CORRELATES WITH LEUKEMIA RELAPSE IN ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Run-Qing Lu, 265956
THE TETRASPANIN CD9 REGULATES GLUCOCORTICOID SENSITIVITY IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Man Hon Li, 265957
KINASE AND CYTOKINE RECEPTOR SIGNALING PATHWAY ACTIVATING ALTERATIONS IN UNIFORMLY TREATED B-ALL
EHA Library, Rimvydas Norvilas, 265958
LONG-TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTS
EHA Library, Andrea Ghelli Luserna di Rora, 265959
ETV6/RUNX1 FUSION GENE ABROGATION DECREASE THE ONCOGENIC POTENCIAL OF TUMORS CELLS IN A PRECLINICAL MODEL OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Adrián Montaño, 265960
DIFFERENTIAL EXPRESSION PATTERNS OF SPECIFIC LONG NONCODING RNAS AND COMPETING ENDOGENOUS RNA NETWORK IN ACUTE LYMPHOCYTE LEUKEMIA
EHA Library, Weimin Wang, 265961
PROSPECTIVE COMPARISON OF SANGER SEQUENCING VS NEXT GENERATION SEQUENCING FOR ROUTINE BCR-ABL1 KINASE DOMAIN MUTATION SCREENING IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Library, Simona SOVERINI, 265962
RESULTS FROM UKALL60+, A UK PHASE 2 STUDY IN ELDERLY PATIENTS WITH UNTREATED ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Library, Adele K. Fielding, 265963
GERIATRIC ASSESSMENT-BASED TREATMENT OF ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS. RESULTS OF THE GIMEMA LAL1104 PROTOCOL
EHA Library, Sabina Chiaretti, 265964
MULTICENTRE STANDARDIZATION OF MINIMAL RESIDUAL DISEASE DETECTION AND QUANTITATION USING THE EUROCLONALITY-NGS ASSAY
EHA Library, Michael Svaton, 265965
MONOCYTIC SWITCH AND DISCREPANCY BETWEEN FLOW CYTOMETRIC AND MOLECULAR MINIMAL RESIDUAL DISEASE ARE FREQUENT IN DUX4 REARRANGED AND PAX5-P80R MUTATED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Michaela Reiterová, 265966
NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUM
EHA Library, Veerle Mondelaers, 265967
DEFINITION OF REPRESENTATIVE BONE MARROW SAMPLE BASED ON PARALLEL EVALUATION OF PERIPHERAL BLOOD DURING THE THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Barbora Vakrmanova, 265968
DIFFERENT IMPACT OF BCR BREAKPOINT ON THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FROM DIFFERENT GRAFT SOURCE FOR PH+ALL IN THE ERA OF TKI
EHA Library, Satoshi Nishiwaki, 265969
THE SIGNIFICANCE OF MONOSOMAL KARYOTYPE IN PHILADELPHIA CHROMOSOME NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Zongru Li, 265970
PEDIATRIC-INSPIRED REGIMEN PLUS HDACI CHIDAMIDE YIELDED PROMISING RESPONSE IN PH-LIKE AND ETP ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Hongsheng Zhou, 265971
CLINICOBIOLOGIC CHARACTERISTICS AND OUTCOME OF ELDERLY FRAIL PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA INCLUDED IN A SPECIFIC PROTOCOL (ALL-07FRAIL)
EHA Library, Josep Maria Ribera, 265972
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CHILDREN WITH HEMATOLOGHIC AND ONCOLOGIC DISEASES: MULTICENTER EXPERIENCE
EHA Library, Özlem Arman Bilir, 265973
EFFICACY OF CONSOLIDATION CHEMOTHERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO ACHIEVED COMPLETE REMISSION BY FIRST COURSE OF REMISSION INDUCTION THERAPY.
EHA Library, Akio Shigematsu, 265974
WT1 OVEREXPRESSION PREDICTED GOOD OUTCOMES IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY
EHA Library, Shujuan Wang, 265975
INTENSIVE CARE OF THE LIFE -THREATING COMPLICATION DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS (PTS)
EHA Library, Aleksei Bazhenov, 265976
LEUKEMIA AND DEPLETED URANIUM IN KOSOVO
EHA Library, Hatixhe Latifi-Pupovci, 265977
NGS COMBINED WITH ASO REAL-TIME PCR BASED MRD DETECTION ASSAY FOR PEDIATRIC ALL PATIENTS
EHA Library, Katerina Nicolaou, 265978
APPROPRIATE INTERVAL OF MONITORING FOR DETECTION OF MOLECULAR RELAPSE AFTER STOP OF TKI IN PH+ALL IN PH+ ALL CALCULATING BY MRD KINETICS
EHA Library, Koichi MIYAMURA, 265979
PLASMA LEVELS AND OUTCOMES OF PROPHYLACTIC POST-TRANSPLANT PONATINIB ADMINISTRATION IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)
EHA Library, Satoru Nanno, 265980
RECLASSIFICATION OF BIPHENOTYPIC ACUTE LEUKEMIA INTO MIXED-PHENOTYPE ACUTE LEUKEMIA ACCORDING TO WHO CRITERIA REFINES PATIENT CHARACTERIZATION AND PROGNOSIS; DISEASE MARKERS AND IMPACT ON OUTCOME
EHA Library, VASILIKI DOUKA, 265981
CLINICAL PROFILE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN HAEMATOLOGY PATIENTS AT A TERTIARY CARE CENTRE
EHA Library, Gopila Gupta, 265982
NO BLASTS AT DAY 8 IS BETTER THAN MORE IN CORTICO-SENSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDREN
EHA Library, Imen Ben Amor, 265983
EVALUATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY AS PROGNOSTIC MARKERS IN A PEDIATRIC PATIENT COHORT WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Monika Haubitz, 265984
THE IMPACT OF COMORBIDITY ON SURVIVAL OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Roberta Demichelis-Gomez, 265985
IDENTICAL TWINS DO NOT DISPLAY INCREASED CONCORDANCE FOR CLONAL HEMATOPOIESIS
EHA Library, Margarete Fabre, 265986
A NEW CLASSIFICATION OF ACUTE MYELOID LEUKEMIA BASED ON INTEGRATED GENOMICS AND METABOLOMICS
EHA Library, Giorgia SIMONETTI, 265987
THE IMPACT OF PPM1D MUTATIONS ON THE DNA DAMAGE RESPONSE AND CLONAL EVOLUTION
EHA Library, Joanne Hsu, 265988
TARGETING BRD4 IN MLL-PTD AML
EHA Library, Felice Pepe, 265989
CARBENOXOLONE REVERSES MICROENVIRONMENT-INDUCED CHEMORESISTANCE OF ACUTE MYELOID LEUKEMIA
EHA Library, Farah KOUZI, 265990
THE COMBINATION OF IMGN632, A CD123-TARGETING ADC, WITH VENETOCLAX ENHANCES ANTI-LEUKEMIC ACTIVITY IN VITRO AND PROLONGS SURVIVAL IN VIVO IN PRE-CLINICAL MODELS OF HUMAN AML
EHA Library, Sharlene Adams, 265991
MONOLINEAGE ORIGIN OF AML RELAPSE FOLLOWING MULTILINEAGE DIFFERENTIATION THERAPY
EHA Library, Steven Ngo, 265992
CG-806, PRECLINICAL IN VIVO EFFICACY AND SAFETY PROFILE AS A PAN-FLT3/PAN-BTK INHIBITOR
EHA Library, Hongying Zhang, 265993
TARP AS IMMUNOTHERAPEUTIC TARGET IN AML EXPRESSED IN THE LSC COMPARTMENT
EHA Library, Barbara Depreter, 265994
RNA BASED IMMUNE SIGNATURES MAY PREDICT RESPONSES TO PD-1 INHIBITION AND AZACITIDINE TREATMENT IN ACUTE MYELOID LEUKEMIA (AML): A SUBSET ANALYSIS OF A PHASE 2 STUDY
EHA Library, Naval Daver, 265995
DUAL TARGETING OF LYSOSOMES AND MITOCHONDRIA BY ANTIHISTAMINES TO ERADICATE LEUKEMIC CELLS
EHA Library, Josep Maria CORNET MASANA, 265996
TARGETING WILMS TUMOR 1 WITH A T CELL BISPECIFIC ANTIBODY (WT1-TCB): EX VIVO AND IN VIVO POTENCY BY BIVALENT RECOGNITION OF PEPTIDE-MHC COMPLEXES FROM AN INTRACELLULAR TUMOR ANTIGEN
EHA Library, Christian Augsberger, 265997
MN1 IS INDISPENSABLE FOR MLL-REARRANGED ACUTE MYELOID LEUKEMIA
EHA Library, Amit Sharma, 265998
INTEGRATIVE FUNCTIONAL ANALYSIS OF THE DEK-NUP214 FUSION PROTEIN IN ACUTE MYELOID LEUKAEMIA
EHA Library, Fabio Liberante, 265999
CLINICAL ASPECTS AND DIFFERENTIAL SPLICING IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SRSF2, U2AF1 AND SF3B1 MUTATIONS
EHA Library, Stefanos Bamopoulos, 266000
MITOCHONDRIAL PRIMING OF BLASTS, BUT NOT LSC, PREDICTS SURVIVAL IN OLDER AML PATIENTS TREATED INTENSIVELY INDEPENDENTLY OF ONCOGENETICS: A STUDY ON THE ALFA 1200 TRIAL
EHA Library, Reinaldo Dal Bello, 266001
NEXT-GENERATION SEQUENCING OF CIRCULATING CELL-FREE DNA PROVIDES COMPLEMENTARY INFORMATION TO GENOMIC PROFILING OF BONE MARROW IN PATIENTS WITH ACUTE LEUKEMIAS
EHA Library, Nicholas Short, 266002
THE GENETIC LANDSCAPE OF FAMILIAL MDS/AML; RECURRING MUTATIONS IN THE RNA HELICASE DHX34 LEADING TO DEFECTS IN NONSENSE-MEDIATED RNA DECAY
EHA Library, Ana RIO-MACHIN, 266003
CRISPR/CAS9 IN VIVO SCREEN REVEALS A CRUCIAL ROLE FOR TMEM63A IN ENGRAFTMENT OF PRIMARY HUMAN ACUTE MYELOID LEUKEMIA CELLS
EHA Library, Lixiazi He, 266004
THE ROLE OF GROWTH FACTOR INDEPENDENCE 1 (GFI1) IN GENOME STABILITY, DNA REPAIR AND LEUKEMIA GENOMIC EVOLUTION
EHA Library, Cyrus Khandanpour, 266005
ROLE OF MEASURABLE RESIDUAL DISEASE (MRD) IN REDEFINING COMPLETE RESPONSE (CR) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PETHEMA-FLUGAZA PHASE III CLINICAL TRIAL
EHA Library, Pau Montesinos, 266006
TARGETING FLT3 IN AML: MODULATION OF FLT3-BITE® ACTIVITY THROUGH COMBINATION WITH VARIOUS TKI
EHA Library, Bettina Brauchle, 266007
DDX11 MUTATIONS AND CLONAL TRAJECTORY PATTERNS IN ADULTS WITH CYTOGENETICALLY-NORMAL ACUTE MYELOID LEUKEMIA
EHA Library, Ya-Lan Zhou, 266008
THE LEDGF/P75 HOMOLOG HRP2 IS NOT IMPORTANT FOR THE INITIATION OF MLL-REARRANGED LEUKEMIA.
EHA Library, Siska Van Belle, 266009
COMPARISON OF FOUR NGS PANELS AND ANALYSIS OF THEIR CLINICAL UTILITY IN MYELOID HEMATOLOGICAL MALIGNANCIES OF THE MYELOID LINAGE
EHA Library, Almudena Aguilera Diaz, 266010
MUTATIONAL PROFILE BY NGS COMBINED WITH EX VIVO DRUG SENSITIVITY PROFILE IMPROVE PREDICTION OF AML PATIENT OUTCOME
EHA Library, Maria Esther Onecha Fuente, 266011
EPIGENETIC SILENCING OF CD9 CONFERS POOR SURVIVAL IN PEDIATRIC ACUTE MYELOID LEUKEMIA AND AGGRAVATES DISEASE PROGRESSION
EHA Library, Han Wang, 266012
CHARACTERIZATION OF KINASE ACTIVITIES INFERRED BY PHOSPHOPROTEOMICS IN MYELOID CELL LINES TREATED WITH TARGETING COMPOUNDS FOR THE IDENTIFICATION OF DRIVING AND BYPASSING ONCOGENIC SIGNALING PATHWAYS
EHA Library, Nicolas Bonadies, 266013
NOVEL ICMT INHIBITOR AS POTENTIAL TREATMENT OF RAS-DRIVEN ACUTE MYELOID LEUKEMIA
EHA Library, Miguel Gallardo, 266014
AZACITIDINE (AZA) ENHANCES ANTILEUKEMIC ACTIVITY OF THE MDM2 INHIBITOR MILADEMETAN IN TP53 WILD-TYPE ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Shingo Noguchi, 266015
AUTOMATIC SEPARATION OF ABERRANT CELL CLUSTERS IN STANDARDIZED FLOW CYTOMETRY EXPERIMENTS PROVIDES A HIGHLY REPRODUCIBLE STRATEGY FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC LEUKEMIA
EHA Library, Vanesa Diaz, 266016
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE
EHA Library, Chiara Caprioli, 266017
DIAGNOSTIC VALUE OF PU.1 LOCALIZATION IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1
EHA Library, Giulia Pianigiani, 266018
CLUSTER ANALYSIS IDENTIFIES A SPECIFIC IMMUNOPHENOTYPIC PROFILE ASSOCIATED WITH HIGH RISK OF PRIMARY INDUCTION FAILURE AND SHORTER OVERALL AND DISEASE-FREE SURVIVAL IN NPM1-MUTATED AML
EHA Library, Matteo Piccini, 266019
THE RNA HELICASE DDX17 PROTECTS ACUTE MYELOID LEUKEMIA CELLS AGAINST DNA DAMAGE
EHA Library, Prarabdha Jagdhane, 266020
REDIRECTED CYTOTOXICITY AND PROLIFERATION OF T CELLS INDUCED BY BITE® ANTIBODY CONSTRUCTS ARE MODULATED BY THE EXPRESSION PROFILE OF COSTIMULATORY AND COINHIBITORY MOLECULES ON TARGET CELLS IN VITRO
EHA Library, Anetta Marcinek, 266021
PROGNOSTIC IMPACT OF THE 2017 EUROPEAN LEUKEMIANET (ELN) CLASSIFICATION OF YOUNGER ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED ON CANCER AND LEUKEMIA GROUP B (CALGB)/ALLIANCE PROTOCOLS
EHA Library, Marius Bill, 266022
SIGNIFICANT REDUCTION OF REGULATORY INNATE LYMPHOID CELLS (ILCREGS, CD45+LIN-CD127+IL-10+) AND CD45+LIN-CD127+IL-10- CELLS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA DETECTED BY FLOW CYTOMETRY
EHA Library, Jifeng Yu, 266024
COMPREHENSIVE GENETIC TEST TO DETECT ALL GENE FUSIONS IN HEMATOLOGICAL MALIGNANCIES?
EHA Library, Eva Van Den Berg-De Ruiter, 266025
IDENTIFICATION OF ACUTE MYELOID LEUKAEMIA STEM CELLS AT DIAGNOSIS REVEALS PHENOTYPIC HETEROGENEITY AND IS FEASIBLE IN A CLINICAL LABORATORY
EHA Library, Shir Ying Lee, 266026
THE PROGNOSTIC IMPACT OF LYMPHOCYTE REPERTOIRE RECOVERY AFTER INDUCTION TREATMENT OF CHILDHOOD AML
EHA Library, Michael Svaton, 266027
TUMOR NGS-PANEL UTILITY IN THE IDENTIFICATION OF GERMLINE VARIANTS IN MYELOID MALIGNANCIES
EHA Library, Sara Palomino-Echeverria, 266028
COMBINED TARGETING OF BCL-2 AND SET-PP2A INTERACTION INDUCES POTENT AND SYNERGISTIC ANTI-LEUKEMIC EFFECTS ON ACUTE MYELOID LEUKEMIA
EHA Library, Irene Peris Martínez, 266029
COMBINED INHIBITION OF SHP1 AND SHP2 WITH PHORBOL ESTERS AS A DIFFERENTIATION THERAPY AGAINST ACUTE MYELOID LEUKEMIA
EHA Library, Alejandro Pérez-Fernández, 266030
TARGETING SET-PP2A INTERACTION AS A NOVEL THERAPEUTIC APPROACH FOR MIXED LINEAGE LEUKEMIA (MLL)
EHA Library, ANTONELLA DI MAMBRO, 266031
LONG NON-CODING RNA MANTIS INHIBITS THE PROLIFERATION OF ACUTE MYELOID LEUKEMIA CELL LINE VIA NOTCH SIGNALING PATHWAY
EHA Library, Hongtao Wang, 266033
AN MLL-AF9 ZEBRAFISH LEUKEMIA MODEL
EHA Library, Maryam Saberi, 266035
ANALYSIS OF THE FUNCTION OF HNRNP K IN PATHOGENESIS OF AML WITH DEL(9Q)
EHA Library, Kerstin Rahn, 266037
METFORMIN INHIBITS THE GROWTH OF MYELOID LEUKEMIA CELLS PARTLY DUE TO SUPPRESSION OF TYRO3 EXPRESSION
EHA Library, Tatsuya Saito, 266039
PERSONALIZED FOLLOW-UP OF ACUTE MYELOID LEUKEMIA THROUGH MULTIPARAMETER FLOW CYTOMETRY: A PROOF OF CONCEPT
EHA Library, Hugues Jacqmin, 266041
CONSEQUENCES OF NRAS MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Anna Durinikova, 266043
THE REGULATORY B CELLS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Hongtao Wang, 266045
NEXT-GENERATION-SEQUENCE-BASED GENE MUTATION DETECTION AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.
EHA Library, Jifeng Yu, 266047
HNRNP K OVEREXPRESSION INDUCE NUCLEOLAR STRESS, A HALLMARK OF ACUTE MYELOID LEUKEMIA
EHA Library, Pedro Aguilar Garrido, 266049
GILTERITINIB PROLONGS SURVIVAL IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML WHO HAVE COMMON AML CO-MUTATIONS OR A HIGH FLT3-ITD ALLELIC RATIO
EHA Library, Mark Levis, 266051
SAFETY AND RESOURCE UTILIZATION FOLLOWING EARLY HOSPITAL DISCHARGE AFTER INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA (AML): A 4-YEAR RETROSPECTIVE ANALYSIS
EHA Library, Nicholas P. Howard, 266053
RESULTS FROM THE FIRST-IN-HUMAN STUDY OF MIVEBRESIB (ABBV-075), A PAN-INHIBITOR OF BROMODOMAIN AND EXTRA TERMINAL PROTEINS, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Library, Gautam Borthakur, 266054
INCIDENCE AND RISK FACTORS FOR EARLY DEATH AMONG 2421 APL PATIENTS: THE PETHEMA REGISTRY EXPERIENCE
EHA Library, Marta Sobas, 266055
RATIFY: PROGNOSTIC IMPACT OF FLT3 TYROSINE KINASE DOMAIN (TKD) AND NPM1 MUTATION STATUS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) TREATED WITH MIDOSTAURIN + STANDARD CHEMOTHERAPY
EHA Library, Maria Teresa Voso, 266056
GEMTUZUMAB OZOGAMICIN COMBINED WITH CYTARABINE FOR ACUTE MYELOID LEUKEMIA PATIENTS IN FIRST RELAPSE
EHA Library, Aude-Marie Fourmont, 266057
REAL-WORLD DATA ON DOSE-RELATED EFFECT OF ARSENIC TRIOXIDE IN THE RELAPSE OF ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Huaiyu Wang, 266058
THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL-INHIBITOR AND LOW-DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY
EHA Library, Sonja Loges, 266059
PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3-ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY
EHA Library, Konstanze Döhner, 266060
A RANDOMIZED, OPEN-LABEL, PHASE II STUDY OF SELINEXOR VERSUS PHYSICIAN’S CHOICE (PC) IN OLDER PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Kendra Sweet, 266061

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings